Browse Studies — Arctuva

Phase 1

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor (TGCT)

Background: \- Some people with cancer have solid tumors. Others have refractory leukemia. This may not go away after treatment. Researchers want to see if a …

Neurofibroma, PlexiformPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Promyelocytic, Acute+1 more

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT02390752

Observational

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

The goal of this study is to test an electronic health (eHealth) mindfulness-based music therapy intervention to improve health-related quality of life and red…

Stem Cell TransplantationMyelodysplastic SyndromesLeukemia, Myeloid, Acute+2 more

Estimated

~$10 – $6,250

University of MiamiNCT07469592

Observational

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Background: Drugs or cell therapies to treat cancer can sometimes cause cytokine release syndrome (CRS). That is, the body makes too many cytokines after trea…

Cytokine Release SyndromeNeoplasmsLymphoma+13 more

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT07499128